Answers are grounded in this paper and cite their sources.
The postmenopausal use of oral estrogens in low doses favorably alters LDL and HDL levels that may protect women against atherosclerosis, while minimizing potentially adverse effects on triglyceride levels. The decrease in LDL levels results from accelerated LDL catabolism; the increase in triglyceride levels results from increased production of large, triglyceride-rich VLDL.
No takes yet. Share an insight, caveat, or question.
Walsh et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: